FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
3,819 letters. Newest first.
-
DrugsJose M. Carpio, M.D.
FDA warned clinical investigator Dr. Jose Carpio of Miami Lakes, FL, that trial subjects received less than the protocol-required dose of study drug.
Medium -
FoodBharat Overseas Inc.
FDA warns New York importer Bharat Overseas for having no foreign supplier verification program for its imported foods.
Medium -
DrugsFagron BV
FDA warns Fagron's Canton, MA sterile compounding site over airflow, cleaning and investigation failures, prompting a recall.
High risk -
DrugsMedline Inc
FDA warned Medline Inc about repeated Bacillus cereus contamination in its drug products and inadequate investigations.
High risk -
BiologicsBlue Horizon International, LLC
FDA warned Blue Horizon International over unapproved stem cell and exosome biologics marketed for serious diseases without a license.
High risk -
DrugsLaboratorios Jaloma S.A. de C.V.
FDA found Laboratorios Jaloma’s OTC drug lab records were inaccurate, microbial tests unvalidated, and electronic data missing or uncontrolled.
High risk -
DrugsAeroflex Industria de Aerosol Ltda.
Brazil OTC drug maker Aeroflex ignored FDA records requests, prompting possible approval holds and US shipment refusals.
High risk -
FoodAversa's Italian Bakery
FDA warns Aversa's Italian Bakery over missing food safety plan and undeclared sesame/milk allergens in ready-to-eat rolls.
High risk -
DrugsHealthPartners Neuroscience Center Research and Innovation
FDA warned HealthPartners Neuroscience Center that its animal studies of an investigational drug violated good laboratory practice rules.
Medium -
FoodMeta Labs Pharmaceuticals, LLC
FDA warns Meta Labs its supplements are unapproved drugs and have serious manufacturing violations.
High risk -
FoodCity Market, Inc.
FDA cited City Market, Inc. for insanitary conditions and seafood safety plan (HACCP) failures involving ready-to-eat pasteurized canned crab meat.
High risk -
FoodDough-To-Go, Inc.
FDA warned Dough-To-Go of Santa Clara, CA after an inspection found insanitary conditions and unused food safety controls at its baked goods plant.
High risk -
FoodBoba Factory Inc
Boba Factory Inc lacked required foreign supplier verification programs for imported non-dairy creamer, flavoring syrup, and dry custard mix.
Medium -
FoodStavis Seafoods, LLC
FDA warned Stavis Seafoods that it lacked a required check for imported frozen aquaculture salmon fillets, making them adulterated.
High risk -
DrugsAlchymars ICM SM Private Limited
FDA found Alchymars API manufacturing had poor equipment and facility maintenance, making its APIs adulterated and prompting an import alert.
High risk -
DrugsSato Pharmaceutical Co., Ltd.
FDA says Sato Pharmaceutical's sterile OTC drug line had contamination and stability failures.
High risk -
DrugsGSC Products, LLC
FDA told GSC Products its Sinus Plumber headache nasal spray is an unapproved new drug sold online without FDA approval.
High risk -
DrugsAja Health and Wellness Inc.
FDA warns Aja Health and Wellness that its Aja Migraine Relief nasal spray is an unapproved, misbranded OTC drug.
Medium -
DrugsGC America, Inc.
FDA warned GC America after an inspection found inadequate component testing, stability data, and quality oversight for its OTC drugs.
High risk -
FoodBest Buy Bones, Inc.
Best Buy Bones pet treats were found with Salmonella and serious animal-food safety and CGMP violations.
High risk -
FoodShineluck Foods, Inc.
FDA warns Shineluck Foods that its mung bean sprouts were held under insanitary conditions with pathogen testing and monitoring failures.
High risk -
FoodZap Expo Center Inc.
Zap Expo Center Inc. lacked required supplier checks for imported foods, FDA found.
Medium -
BiologicsAdnan Dahdul, MD
FDA warns clinical investigator Dr. Adnan Dahdul over consent, eligibility and record failures in a biologics study.
High risk -
Tobaccogethyppe.com
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
Tobaccopouchline.com
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
Tobacconpouches.com
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
Tobaccopouchew.com
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
Tobaccovapetrinity.com
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
TobaccoSmoker Business
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
Tobaccosnusguys.com
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
Tobaccovapenovaco.com
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
Tobaccovape4sale.com
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
DrugsLus Essentials LLC
FDA warned Lus Essentials that its Dr. Yanhee skin treatment and lightening products are unapproved, misbranded drugs and contain high mercury.
High risk -
DrugsLa Crema De Rebeca
La Crema De Rebeca's skin-lightening cream is an unapproved, misbranded drug containing high mercury, FDA warns.
High risk -
DrugsPolleyMed, LLC
FDA says PolleyMed's SaniiSwab nasal swab is an unapproved, misbranded drug sold online with infection-prevention claims and a false FDA approval claim.
High risk -
Tobaccowaterbedsnstuff.com
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
Tobaccoct-riecig.com
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
DrugsNaseem A. Jaffrani, M.D.
FDA says clinical investigator Dr. Naseem Jaffrani failed to report serious adverse events to sponsors within 24 hours in two drug trials.
High risk -
DrugsHarbin Jixianglong Biotech Co., Ltd.
FDA warned Harbin Jixianglong Biotech over CGMP (manufacturing quality rules) failures and misbranded relabeled semaglutide API with false manufacturer labels and missing drug listings.
High risk -
DrugsSourav K. Mishra, M.D. / All India Institute of Medical Sciences
FDA warned clinical investigator Dr. Sourav K. Mishra at AIIMS Bhubaneswar over a doxorubicin liposome bioequivalence study that broke protocol and consent rules.
High risk -
FoodSahara Enterprise Inc.
FDA warns Sahara Enterprise Inc. over missing FSVP for imported phyllo dough, Turkish delight, and baklava.
Medium -
FoodGreat One Trading Inc.
FDA warns Brooklyn importer Great One Trading that it had no foreign supplier verification program for the foods it imports.
Medium -
DrugsHangzhou Yiqi Biotechnology Co., Ltd
FDA cited Hangzhou Yiqi Biotechnology, an API maker in China, for four manufacturing practice failures found in a records review.
High risk -
DrugsJW Nutritional LLC
FDA warns JW Nutritional over serious CGMP failures in OTC drug manufacturing, including untested components and inadequate microbial limits.
High risk -
DrugsIDO Pharm Co., Ltd.
IDO Pharm, South Korean drug manufacturer, cited for good manufacturing practice violations including unvalidated system and test methods.
High risk -
DrugsNaveh Pharma LTD/Bigdam Inc.
FDA says Naveh Pharma and Bigdam sell unapproved saline drug products in the U.S. and have no quality unit.
High risk -
Tobaccoswisschlz.com
Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
-
FoodOptiHealth Products, Inc.
FDA warned OptiHealth Products over website claims that Super Antioxidant (OPCXtra) is a drug for diseases like diabetes and Alzheimer's.
Low -
DrugsMukesh B. Chandre, M.D., MBBS/Ashirwad Hospital & Research Centre
FDA warned clinical investigator Dr. Mukesh Chandre over informed consent failures in a doxorubicin liposome bioequivalence study.
High risk -
FoodMinh Phung, Inc.
FDA warns Minh Phung, Inc. over insanitary conditions and time-temperature abuse in refrigerated rice noodles and rice cakes.
High risk